Croda Pharma ’s Post

Croda Pharma reposted this

View organization page for Cell and Gene Therapy Catapult, graphic

48,280 followers

Today we announce the establishment of a new cross-industry consortium to improve the understanding and process optimisation of adeno-associated virus (AAV) formulation. The consortium comprises Croda, ikarovec , UCL's department of Biochemical Engineering, and the Cell and Gene Therapy Catapult (CGT Catapult).   Initial scoping of the consortium was conducted by the CGT Catapult, which included interviews with key opinion leaders and a stakeholder workshop, revealing AAV formulation and stability characterisation as an important, underdeveloped area of unmet need.   The project has received funding from Innovate UK, through its Transforming Medicines Manufacturing Programme   Learn more: https://lnkd.in/dsk6TNtB   #transformingmedicinesmanufacturing #advancedtherapies #AAV #genetherapy

CGT Catapult establishes consortium to improve AAV formulation

CGT Catapult establishes consortium to improve AAV formulation

ct.catapult.org.uk

Emily Francesca Warner

Principal Scientist at Ikarovec Limited

3mo

Such an important topic and a great consortium to be a part of! 🤝 I look forward to sharing our progress with the gene therapy community 💡 #bettermedicines

Jawad Abbas

Marketing Executive @ RPK Reports | Market Research

3mo

Congratulations on this significant consortium, CGT Catapult. Excited to see advancements in AAV formulation!

Spencer Knight

Shaping The Future of Advanced Therapies

3mo

Excellent news for Gene Therapy. Congratulations all

Rachel Naor

Senior Director, Project Management | Subject Matter Expert, Clinical Trials | Cell and Gene Therapies

3mo

Great news!

Like
Reply
See more comments

To view or add a comment, sign in

Explore topics